Rigel Pharmaceuticals Inc (RIGL)
Cost of Revenue
$8.53M
Quarterly · Period ending: · USD
RIGL Cost of Revenue
Latest reported$8.53Mperiod ending
Latest reported$8.53Mperiod ending
RIGL Quarterly Cost of Revenue ($0.00 → $8.53M)
Quarterly cost of revenue
High-resolution chart · PNG
RIGL cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 8,525,000 | |
| 4,606,000 | |
| 5,955,000 | |
| 4,753,000 | |
| 4,504,000 | |
| 4,409,000 | |
| 5,789,000 | |
| 8,026,000 | |
| 2,807,000 | |
| 2,025,000 | |
| 3,790,000 | |
| 1,268,000 | |
| 1,075,000 | |
| 977,000 | |
| 342,000 | |
| 250,000 | |
| 1,036,000 | |
| 121,000 | |
| 487,000 | |
| 151,000 | |
| 129,000 | |
| 316,000 | |
| 321,000 | |
| 140,000 | |
| 279,000 | |
| 155,000 | |
| 178,000 | |
| 310,000 | |
| 311,000 | |
| 107,000 | |
| 188,000 | |
| 69,000 | |
| 30,000 | |
| 11,242,000 | |
| 11,561,000 | |
| 10,808,000 | |
| 11,524,000 | |
| 12,376,000 | |
| 11,634,000 | |
| 16,171,000 | |
| 17,468,000 | |
| 18,173,000 | |
| 16,563,000 | |
| 15,501,000 | |
| 15,059,000 | |
| 15,702,000 | |
| 14,613,000 | |
| 16,151,000 | |
| 20,063,000 | |
| 16,869,000 | |
| 18,046,000 | |
| 17,574,000 | |
| 19,393,000 | |
| 20,315,000 | |
| 19,764,000 | |
| 20,186,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |